Cryobanks India Begins an Era of Automation in Stem Cell Banking with Swiss Partner Biosafe

Cryobanks India Begins an Era of Automation in Stem Cell Banking with Swiss Partner Biosafe

Gurgaon, Haryana (PRWEB) – Cryobanks International India, a leader in umbilical cord blood stem cell banking In India, has entered into an agreement with Biosafe S. A., Switzerland, which is the industry leader providing an extremely stable platform for processing cord blood utilizing a closed-system technology named SEPAX®.

Source: Cryobanks India / PRWeb (Link to full release)

About the author

Amitabh Arora

Amitabh Arora

Amitabh Arora has more than 18 years of experience promoting foreign direct investments (FDI), trade and economic relations between India and Switzerland, South Korea, United Kingdom and Canada. He is currently working as Director Key Accounts at the Greater Geneva Berne area (GGBa), the economic development agency of western Switzerland. GGBa offers a comprehensive range of services at no charge to foreign companies seeking to establish a presence in Switzerland. He is also the founder of FDITracker.com, tracking FDI developments worldwide. Amitabh has a Masters in International Business from the Indian Institute of Foreign Trade (IIFT) and a Bachelor of Business Studies (BBS) from College of Business Studies, India.

    Leave a Reply